Company intelligence / Profile preview

CV Technologies

Edmonton, Alberta, Canadacvtechnologies.com ↗

Ownership: Private
Development stage: Commercial

Overview

CV Technologies was best known for developing Cold-fX, an over-the-counter ginseng-based supplement marketed for immune support and cold/flu symptom reduction. The product achieved significant commercial success in Canada but faced regulatory scrutiny regarding efficacy claims. No clinical-stage pharmaceutical assets were reported.

Therapeutic areas: ImmunologyInfectious Diseases
Modalities: Small moleculeNatural product extract
Industry: Food & Nutrition

Beyond the preview

Go deeper on CV Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CV Technologies.

Explore the full profile